Work

A multicenter phase II study of docosahexaenoic acid (DHA) in patients (pts) with a history of breast cancer (BC), premalignant lesions, or benign breast disease.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.tps1615

Authors: Ayca Gucalp, Patrick Glyn Morris, Xi Kathy Zhou, Dilip D. Giri, Neil M. Iyengar, Katherine D. Crew, Dawn L. Hershman, Judy Ellen Garber, Julie R. Nangia, Elise D. Cook, Lana Vornik, Barbara Karen Dunn, Brandy M. Heckman-Stoddard, Kathleen Foster, Powel Brown, Andrew Dannenberg, Clifford A. Hudis

Institutions: Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, Columbia University Irving Medical Center, Dana-Farber Cancer Institute, Baylor College of Medicine, The University of Texas MD Anderson Cancer Center, National Cancer Institute, National Institutes of Health

Language: English

Topic: Fatty Acid Research and Health

Subfield: Nutrition and Dietetics

Field: Nursing

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2599713591

Cites:

Cited by: 2

Related to: 10